Cell cycle and apoptosis regulators

Cell cycle and apoptosis regulators represent a broad functional class of proteins responsible for maintaining cellular homeostasis by controlling cell division and programmed cell death. This category includes critical therapeutic targets such as cyclin-dependent kinases (CDKs), the BCL-2 protein family, and the p53 signaling network (Source: Nature Reviews Molecular Cell Biology, 2001). These molecules act as checkpoints that monitor genomic integrity; their dysfunction is a fundamental hallmark of oncogenesis, enabling cells to proliferate indefinitely and resist cytotoxic stress (Source: Cell, 2011). Pharmacological intervention in these pathways aims to exploit the addiction of cancer cells to specific survival signals or to bypass defective checkpoints. Current clinical successes include CDK4/6 inhibitors like palbociclib and BCL-2 antagonists like venetoclax, which have transformed the treatment landscape for various malignancies (Source: Lancet Oncology, 2019). However, targeting these fundamental processes requires careful management of systemic toxicities, such as myelosuppression, due to the essential roles these regulators play in normal tissue turnover.

Other names

Cell cycle control proteinsApoptotic signaling moleculesProgrammed cell death regulatorsCell cycle and apoptosis machineryCell cycle and apoptosis regulator protein

Drugs targeting this functional class typically act by inhibiting cyclin-dependent kinases (CDKs) to induce cell cycle arrest or by antagonizing anti-apoptotic proteins such as BCL-2 to trigger programmed cell death in malignant cells (Source: Nature Reviews Drug Discovery, 2017).